The global Therapeutic Radioisotopes market is projected to grow from US$ 2036 million in 2024 to US$ 4734 million by 2030, at a Compound Annual Growth Rate (CAGR) of 15.1% during the forecast period.

Therapeutic Radioisotopes Market

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Therapeutic Radioisotopes, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Therapeutic Radioisotopes, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Therapeutic Radioisotopes, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Therapeutic Radioisotopes sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Therapeutic Radioisotopes market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Therapeutic Radioisotopes sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Therapeutic Radioisotopes Market Report

Report Metric	Details
Report Name	Therapeutic Radioisotopes Market
Accounted market size in 2024	US$ 2036 million
Forecasted market size in 2030	US$ 4734 million
CAGR	15.1
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Radium-223 Lutetium-177 Iodine-131 Other
Segment by Application	Thyroid Bone Metastasis Lymphoma Other
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	China Isotope & Radiation, Dongcheng, Q BioMed, Curium Pharmaceuticals, Jubilant Radiopharma, Lantheus, Aurobindo Pharma, International Isotopes, Mundipharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Therapeutic Radioisotopes in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Therapeutic Radioisotopes manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Therapeutic Radioisotopes sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Therapeutic Radioisotopes Market growing?

Ans: The Therapeutic Radioisotopes Market witnessing a CAGR of 15.1 during the forecast period 2025-2030.

What is the Therapeutic Radioisotopes Market size in 2030?

Ans: The Therapeutic Radioisotopes Market size in 2030 will be US$ 4734 million.

Who are the main players in the Therapeutic Radioisotopes Market report?

Ans: The main players in the Therapeutic Radioisotopes Market are China Isotope & Radiation, Dongcheng, Q BioMed, Curium Pharmaceuticals, Jubilant Radiopharma, Lantheus, Aurobindo Pharma, International Isotopes, Mundipharma

What are the Application segmentation covered in the Therapeutic Radioisotopes Market report?

Ans: The Applications covered in the Therapeutic Radioisotopes Market report are Thyroid, Bone Metastasis, Lymphoma, Other

What are the Type segmentation covered in the Therapeutic Radioisotopes Market report?

Ans: The Types covered in the Therapeutic Radioisotopes Market report are Radium-223, Lutetium-177, Iodine-131, Other

1 Study Coverage

1.1 Therapeutic Radioisotopes Product Introduction

1.2 Market by Type

1.2.1 Global Therapeutic Radioisotopes Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Radium-223

1.2.3 Lutetium-177

1.2.4 Iodine-131

1.2.5 Other

1.3 Market by Application

1.3.1 Global Therapeutic Radioisotopes Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Thyroid

1.3.3 Bone Metastasis

1.3.4 Lymphoma

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Therapeutic Radioisotopes Sales Estimates and Forecasts 2019-2030

2.2 Global Therapeutic Radioisotopes Revenue by Region

2.2.1 Global Therapeutic Radioisotopes Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Therapeutic Radioisotopes Revenue by Region (2019-2024)

2.2.3 Global Therapeutic Radioisotopes Revenue by Region (2025-2030)

2.2.4 Global Therapeutic Radioisotopes Revenue Market Share by Region (2019-2030)

2.3 Global Therapeutic Radioisotopes Sales Estimates and Forecasts 2019-2030

2.4 Global Therapeutic Radioisotopes Sales by Region

2.4.1 Global Therapeutic Radioisotopes Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Therapeutic Radioisotopes Sales by Region (2019-2024)

2.4.3 Global Therapeutic Radioisotopes Sales by Region (2025-2030)

2.4.4 Global Therapeutic Radioisotopes Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Therapeutic Radioisotopes Sales by Manufacturers

3.1.1 Global Therapeutic Radioisotopes Sales by Manufacturers (2019-2024)

3.1.2 Global Therapeutic Radioisotopes Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Therapeutic Radioisotopes in 2023

3.2 Global Therapeutic Radioisotopes Revenue by Manufacturers

3.2.1 Global Therapeutic Radioisotopes Revenue by Manufacturers (2019-2024)

3.2.2 Global Therapeutic Radioisotopes Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Therapeutic Radioisotopes Revenue in 2023

3.3 Global Key Players of Therapeutic Radioisotopes, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Therapeutic Radioisotopes Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Therapeutic Radioisotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Therapeutic Radioisotopes, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Therapeutic Radioisotopes, Product Offered and Application

3.8 Global Key Manufacturers of Therapeutic Radioisotopes, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Therapeutic Radioisotopes Sales by Type

4.1.1 Global Therapeutic Radioisotopes Historical Sales by Type (2019-2024)

4.1.2 Global Therapeutic Radioisotopes Forecasted Sales by Type (2025-2030)

4.1.3 Global Therapeutic Radioisotopes Sales Market Share by Type (2019-2030)

4.2 Global Therapeutic Radioisotopes Revenue by Type

4.2.1 Global Therapeutic Radioisotopes Historical Revenue by Type (2019-2024)

4.2.2 Global Therapeutic Radioisotopes Forecasted Revenue by Type (2025-2030)

4.2.3 Global Therapeutic Radioisotopes Revenue Market Share by Type (2019-2030)

4.3 Global Therapeutic Radioisotopes Price by Type

4.3.1 Global Therapeutic Radioisotopes Price by Type (2019-2024)

4.3.2 Global Therapeutic Radioisotopes Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Therapeutic Radioisotopes Sales by Application

5.1.1 Global Therapeutic Radioisotopes Historical Sales by Application (2019-2024)

5.1.2 Global Therapeutic Radioisotopes Forecasted Sales by Application (2025-2030)

5.1.3 Global Therapeutic Radioisotopes Sales Market Share by Application (2019-2030)

5.2 Global Therapeutic Radioisotopes Revenue by Application

5.2.1 Global Therapeutic Radioisotopes Historical Revenue by Application (2019-2024)

5.2.2 Global Therapeutic Radioisotopes Forecasted Revenue by Application (2025-2030)

5.2.3 Global Therapeutic Radioisotopes Revenue Market Share by Application (2019-2030)

5.3 Global Therapeutic Radioisotopes Price by Application

5.3.1 Global Therapeutic Radioisotopes Price by Application (2019-2024)

5.3.2 Global Therapeutic Radioisotopes Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Therapeutic Radioisotopes Market Size by Type

6.1.1 US & Canada Therapeutic Radioisotopes Sales by Type (2019-2030)

6.1.2 US & Canada Therapeutic Radioisotopes Revenue by Type (2019-2030)

6.2 US & Canada Therapeutic Radioisotopes Market Size by Application

6.2.1 US & Canada Therapeutic Radioisotopes Sales by Application (2019-2030)

6.2.2 US & Canada Therapeutic Radioisotopes Revenue by Application (2019-2030)

6.3 US & Canada Therapeutic Radioisotopes Market Size by Country

6.3.1 US & Canada Therapeutic Radioisotopes Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Therapeutic Radioisotopes Sales by Country (2019-2030)

6.3.3 US & Canada Therapeutic Radioisotopes Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Therapeutic Radioisotopes Market Size by Type

7.1.1 Europe Therapeutic Radioisotopes Sales by Type (2019-2030)

7.1.2 Europe Therapeutic Radioisotopes Revenue by Type (2019-2030)

7.2 Europe Therapeutic Radioisotopes Market Size by Application

7.2.1 Europe Therapeutic Radioisotopes Sales by Application (2019-2030)

7.2.2 Europe Therapeutic Radioisotopes Revenue by Application (2019-2030)

7.3 Europe Therapeutic Radioisotopes Market Size by Country

7.3.1 Europe Therapeutic Radioisotopes Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Therapeutic Radioisotopes Sales by Country (2019-2030)

7.3.3 Europe Therapeutic Radioisotopes Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Therapeutic Radioisotopes Market Size

8.1.1 China Therapeutic Radioisotopes Sales (2019-2030)

8.1.2 China Therapeutic Radioisotopes Revenue (2019-2030)

8.2 China Therapeutic Radioisotopes Market Size by Application

8.2.1 China Therapeutic Radioisotopes Sales by Application (2019-2030)

8.2.2 China Therapeutic Radioisotopes Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Therapeutic Radioisotopes Market Size by Type

9.1.1 Asia Therapeutic Radioisotopes Sales by Type (2019-2030)

9.1.2 Asia Therapeutic Radioisotopes Revenue by Type (2019-2030)

9.2 Asia Therapeutic Radioisotopes Market Size by Application

9.2.1 Asia Therapeutic Radioisotopes Sales by Application (2019-2030)

9.2.2 Asia Therapeutic Radioisotopes Revenue by Application (2019-2030)

9.3 Asia Therapeutic Radioisotopes Sales by Region

9.3.1 Asia Therapeutic Radioisotopes Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Therapeutic Radioisotopes Revenue by Region (2019-2030)

9.3.3 Asia Therapeutic Radioisotopes Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Therapeutic Radioisotopes Market Size by Type

10.1.1 Middle East, Africa and Latin America Therapeutic Radioisotopes Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Therapeutic Radioisotopes Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Therapeutic Radioisotopes Market Size by Application

10.2.1 Middle East, Africa and Latin America Therapeutic Radioisotopes Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Therapeutic Radioisotopes Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Therapeutic Radioisotopes Sales by Country

10.3.1 Middle East, Africa and Latin America Therapeutic Radioisotopes Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Therapeutic Radioisotopes Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Therapeutic Radioisotopes Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Bayer

11.1.1 Bayer Company Information

11.1.2 Bayer Overview

11.1.3 Bayer Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Bayer Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Bayer Recent Developments

11.2 Novartis

11.2.1 Novartis Company Information

11.2.2 Novartis Overview

11.2.3 Novartis Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Novartis Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Novartis Recent Developments

11.3 China Isotope & Radiation

11.3.1 China Isotope & Radiation Company Information

11.3.2 China Isotope & Radiation Overview

11.3.3 China Isotope & Radiation Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 China Isotope & Radiation Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 China Isotope & Radiation Recent Developments

11.4 Dongcheng

11.4.1 Dongcheng Company Information

11.4.2 Dongcheng Overview

11.4.3 Dongcheng Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Dongcheng Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Dongcheng Recent Developments

11.5 Q BioMed

11.5.1 Q BioMed Company Information

11.5.2 Q BioMed Overview

11.5.3 Q BioMed Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Q BioMed Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Q BioMed Recent Developments

11.6 Curium Pharmaceuticals

11.6.1 Curium Pharmaceuticals Company Information

11.6.2 Curium Pharmaceuticals Overview

11.6.3 Curium Pharmaceuticals Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Curium Pharmaceuticals Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Curium Pharmaceuticals Recent Developments

11.7 Jubilant Radiopharma

11.7.1 Jubilant Radiopharma Company Information

11.7.2 Jubilant Radiopharma Overview

11.7.3 Jubilant Radiopharma Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Jubilant Radiopharma Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Jubilant Radiopharma Recent Developments

11.8 Lantheus

11.8.1 Lantheus Company Information

11.8.2 Lantheus Overview

11.8.3 Lantheus Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Lantheus Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Lantheus Recent Developments

11.9 Aurobindo Pharma

11.9.1 Aurobindo Pharma Company Information

11.9.2 Aurobindo Pharma Overview

11.9.3 Aurobindo Pharma Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 Aurobindo Pharma Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Aurobindo Pharma Recent Developments

11.10 International Isotopes

11.10.1 International Isotopes Company Information

11.10.2 International Isotopes Overview

11.10.3 International Isotopes Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2019-2024)

11.10.4 International Isotopes Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 International Isotopes Recent Developments

11.11 Mundipharma

11.11.1 Mundipharma Company Information

11.11.2 Mundipharma Overview

11.11.3 Mundipharma Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2019-2024)

11.11.4 Mundipharma Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 Mundipharma Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Therapeutic Radioisotopes Industry Chain Analysis

12.2 Therapeutic Radioisotopes Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Therapeutic Radioisotopes Production Mode & Process

12.4 Therapeutic Radioisotopes Sales and Marketing

12.4.1 Therapeutic Radioisotopes Sales Channels

12.4.2 Therapeutic Radioisotopes Distributors

12.5 Therapeutic Radioisotopes Customers

13 Market Dynamics

13.1 Therapeutic Radioisotopes Industry Trends

13.2 Therapeutic Radioisotopes Market Drivers

13.3 Therapeutic Radioisotopes Market Challenges

13.4 Therapeutic Radioisotopes Market Restraints

14 Key Findings in The Global Therapeutic Radioisotopes Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Bayer

Novartis

China Isotope & Radiation

Dongcheng

Q BioMed

Curium Pharmaceuticals

Lantheus

International Isotopes

Jubilant Radiopharma

Aurobindo Pharma

Mundipharma

List of Tables

Table 1. Global Therapeutic Radioisotopes Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Radium-223

Table 3. Major Manufacturers of Lutetium-177

Table 4. Major Manufacturers of Iodine-131

Table 5. Major Manufacturers of Other

Table 6. Global Therapeutic Radioisotopes Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Therapeutic Radioisotopes Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global Therapeutic Radioisotopes Revenue by Region (2019-2024) & (US$ Million)

Table 9. Global Therapeutic Radioisotopes Revenue by Region (2025-2030) & (US$ Million)

Table 10. Global Therapeutic Radioisotopes Revenue Market Share by Region (2019-2024)

Table 11. Global Therapeutic Radioisotopes Revenue Market Share by Region (2025-2030)

Table 12. Global Therapeutic Radioisotopes Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 13. Global Therapeutic Radioisotopes Sales by Region (2019-2024) & (K Units)

Table 14. Global Therapeutic Radioisotopes Sales by Region (2025-2030) & (K Units)

Table 15. Global Therapeutic Radioisotopes Sales Market Share by Region (2019-2024)

Table 16. Global Therapeutic Radioisotopes Sales Market Share by Region (2025-2030)

Table 17. Global Therapeutic Radioisotopes Sales by Manufacturers (2019-2024) & (K Units)

Table 18. Global Therapeutic Radioisotopes Sales Share by Manufacturers (2019-2024)

Table 19. Global Therapeutic Radioisotopes Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 20. Global Therapeutic Radioisotopes Revenue Share by Manufacturers (2019-2024)

Table 21. Global Key Players of Therapeutic Radioisotopes, Industry Ranking, 2022 VS 2023 VS 2024

Table 22. Therapeutic Radioisotopes Price by Manufacturers 2019-2024 (USD/Unit)

Table 23. Global Therapeutic Radioisotopes Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 24. Global Therapeutic Radioisotopes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Radioisotopes as of 2023)

Table 25. Global Key Manufacturers of Therapeutic Radioisotopes, Manufacturing Base Distribution and Headquarters

Table 26. Global Key Manufacturers of Therapeutic Radioisotopes, Product Offered and Application

Table 27. Global Key Manufacturers of Therapeutic Radioisotopes, Date of Enter into This Industry

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Therapeutic Radioisotopes Sales by Type (2019-2024) & (K Units)

Table 30. Global Therapeutic Radioisotopes Sales by Type (2025-2030) & (K Units)

Table 31. Global Therapeutic Radioisotopes Sales Share by Type (2019-2024)

Table 32. Global Therapeutic Radioisotopes Sales Share by Type (2025-2030)

Table 33. Global Therapeutic Radioisotopes Revenue by Type (2019-2024) & (US$ Million)

Table 34. Global Therapeutic Radioisotopes Revenue by Type (2025-2030) & (US$ Million)

Table 35. Global Therapeutic Radioisotopes Revenue Share by Type (2019-2024)

Table 36. Global Therapeutic Radioisotopes Revenue Share by Type (2025-2030)

Table 37. Therapeutic Radioisotopes Price by Type (2019-2024) & (USD/Unit)

Table 38. Global Therapeutic Radioisotopes Price Forecast by Type (2025-2030) & (USD/Unit)

Table 39. Global Therapeutic Radioisotopes Sales by Application (2019-2024) & (K Units)

Table 40. Global Therapeutic Radioisotopes Sales by Application (2025-2030) & (K Units)

Table 41. Global Therapeutic Radioisotopes Sales Share by Application (2019-2024)

Table 42. Global Therapeutic Radioisotopes Sales Share by Application (2025-2030)

Table 43. Global Therapeutic Radioisotopes Revenue by Application (2019-2024) & (US$ Million)

Table 44. Global Therapeutic Radioisotopes Revenue by Application (2025-2030) & (US$ Million)

Table 45. Global Therapeutic Radioisotopes Revenue Share by Application (2019-2024)

Table 46. Global Therapeutic Radioisotopes Revenue Share by Application (2025-2030)

Table 47. Therapeutic Radioisotopes Price by Application (2019-2024) & (USD/Unit)

Table 48. Global Therapeutic Radioisotopes Price Forecast by Application (2025-2030) & (USD/Unit)

Table 49. US & Canada Therapeutic Radioisotopes Sales by Type (2019-2024) & (K Units)

Table 50. US & Canada Therapeutic Radioisotopes Sales by Type (2025-2030) & (K Units)

Table 51. US & Canada Therapeutic Radioisotopes Revenue by Type (2019-2024) & (US$ Million)

Table 52. US & Canada Therapeutic Radioisotopes Revenue by Type (2025-2030) & (US$ Million)

Table 53. US & Canada Therapeutic Radioisotopes Sales by Application (2019-2024) & (K Units)

Table 54. US & Canada Therapeutic Radioisotopes Sales by Application (2025-2030) & (K Units)

Table 55. US & Canada Therapeutic Radioisotopes Revenue by Application (2019-2024) & (US$ Million)

Table 56. US & Canada Therapeutic Radioisotopes Revenue by Application (2025-2030) & (US$ Million)

Table 57. US & Canada Therapeutic Radioisotopes Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 58. US & Canada Therapeutic Radioisotopes Revenue by Country (2019-2024) & (US$ Million)

Table 59. US & Canada Therapeutic Radioisotopes Revenue by Country (2025-2030) & (US$ Million)

Table 60. US & Canada Therapeutic Radioisotopes Sales by Country (2019-2024) & (K Units)

Table 61. US & Canada Therapeutic Radioisotopes Sales by Country (2025-2030) & (K Units)

Table 62. Europe Therapeutic Radioisotopes Sales by Type (2019-2024) & (K Units)

Table 63. Europe Therapeutic Radioisotopes Sales by Type (2025-2030) & (K Units)

Table 64. Europe Therapeutic Radioisotopes Revenue by Type (2019-2024) & (US$ Million)

Table 65. Europe Therapeutic Radioisotopes Revenue by Type (2025-2030) & (US$ Million)

Table 66. Europe Therapeutic Radioisotopes Sales by Application (2019-2024) & (K Units)

Table 67. Europe Therapeutic Radioisotopes Sales by Application (2025-2030) & (K Units)

Table 68. Europe Therapeutic Radioisotopes Revenue by Application (2019-2024) & (US$ Million)

Table 69. Europe Therapeutic Radioisotopes Revenue by Application (2025-2030) & (US$ Million)

Table 70. Europe Therapeutic Radioisotopes Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 71. Europe Therapeutic Radioisotopes Revenue by Country (2019-2024) & (US$ Million)

Table 72. Europe Therapeutic Radioisotopes Revenue by Country (2025-2030) & (US$ Million)

Table 73. Europe Therapeutic Radioisotopes Sales by Country (2019-2024) & (K Units)

Table 74. Europe Therapeutic Radioisotopes Sales by Country (2025-2030) & (K Units)

Table 75. China Therapeutic Radioisotopes Sales by Type (2019-2024) & (K Units)

Table 76. China Therapeutic Radioisotopes Sales by Type (2025-2030) & (K Units)

Table 77. China Therapeutic Radioisotopes Revenue by Type (2019-2024) & (US$ Million)

Table 78. China Therapeutic Radioisotopes Revenue by Type (2025-2030) & (US$ Million)

Table 79. China Therapeutic Radioisotopes Sales by Application (2019-2024) & (K Units)

Table 80. China Therapeutic Radioisotopes Sales by Application (2025-2030) & (K Units)

Table 81. China Therapeutic Radioisotopes Revenue by Application (2019-2024) & (US$ Million)

Table 82. China Therapeutic Radioisotopes Revenue by Application (2025-2030) & (US$ Million)

Table 83. Asia Therapeutic Radioisotopes Sales by Type (2019-2024) & (K Units)

Table 84. Asia Therapeutic Radioisotopes Sales by Type (2025-2030) & (K Units)

Table 85. Asia Therapeutic Radioisotopes Revenue by Type (2019-2024) & (US$ Million)

Table 86. Asia Therapeutic Radioisotopes Revenue by Type (2025-2030) & (US$ Million)

Table 87. Asia Therapeutic Radioisotopes Sales by Application (2019-2024) & (K Units)

Table 88. Asia Therapeutic Radioisotopes Sales by Application (2025-2030) & (K Units)

Table 89. Asia Therapeutic Radioisotopes Revenue by Application (2019-2024) & (US$ Million)

Table 90. Asia Therapeutic Radioisotopes Revenue by Application (2025-2030) & (US$ Million)

Table 91. Asia Therapeutic Radioisotopes Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 92. Asia Therapeutic Radioisotopes Revenue by Region (2019-2024) & (US$ Million)

Table 93. Asia Therapeutic Radioisotopes Revenue by Region (2025-2030) & (US$ Million)

Table 94. Asia Therapeutic Radioisotopes Sales by Region (2019-2024) & (K Units)

Table 95. Asia Therapeutic Radioisotopes Sales by Region (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Therapeutic Radioisotopes Sales by Type (2019-2024) & (K Units)

Table 97. Middle East, Africa and Latin America Therapeutic Radioisotopes Sales by Type (2025-2030) & (K Units)

Table 98. Middle East, Africa and Latin America Therapeutic Radioisotopes Revenue by Type (2019-2024) & (US$ Million)

Table 99. Middle East, Africa and Latin America Therapeutic Radioisotopes Revenue by Type (2025-2030) & (US$ Million)

Table 100. Middle East, Africa and Latin America Therapeutic Radioisotopes Sales by Application (2019-2024) & (K Units)

Table 101. Middle East, Africa and Latin America Therapeutic Radioisotopes Sales by Application (2025-2030) & (K Units)

Table 102. Middle East, Africa and Latin America Therapeutic Radioisotopes Revenue by Application (2019-2024) & (US$ Million)

Table 103. Middle East, Africa and Latin America Therapeutic Radioisotopes Revenue by Application (2025-2030) & (US$ Million)

Table 104. Middle East, Africa and Latin America Therapeutic Radioisotopes Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 105. Middle East, Africa and Latin America Therapeutic Radioisotopes Revenue by Country (2019-2024) & (US$ Million)

Table 106. Middle East, Africa and Latin America Therapeutic Radioisotopes Revenue by Country (2025-2030) & (US$ Million)

Table 107. Middle East, Africa and Latin America Therapeutic Radioisotopes Sales by Country (2019-2024) & (K Units)

Table 108. Middle East, Africa and Latin America Therapeutic Radioisotopes Sales by Country (2025-2030) & (K Units)

Table 109. Bayer Company Information

Table 110. Bayer Description and Major Businesses

Table 111. Bayer Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 112. Bayer Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications

Table 113. Bayer Recent Developments

Table 114. Novartis Company Information

Table 115. Novartis Description and Major Businesses

Table 116. Novartis Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 117. Novartis Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications

Table 118. Novartis Recent Developments

Table 119. China Isotope & Radiation Company Information

Table 120. China Isotope & Radiation Description and Major Businesses

Table 121. China Isotope & Radiation Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 122. China Isotope & Radiation Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications

Table 123. China Isotope & Radiation Recent Developments

Table 124. Dongcheng Company Information

Table 125. Dongcheng Description and Major Businesses

Table 126. Dongcheng Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 127. Dongcheng Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications

Table 128. Dongcheng Recent Developments

Table 129. Q BioMed Company Information

Table 130. Q BioMed Description and Major Businesses

Table 131. Q BioMed Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 132. Q BioMed Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications

Table 133. Q BioMed Recent Developments

Table 134. Curium Pharmaceuticals Company Information

Table 135. Curium Pharmaceuticals Description and Major Businesses

Table 136. Curium Pharmaceuticals Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 137. Curium Pharmaceuticals Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications

Table 138. Curium Pharmaceuticals Recent Developments

Table 139. Jubilant Radiopharma Company Information

Table 140. Jubilant Radiopharma Description and Major Businesses

Table 141. Jubilant Radiopharma Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 142. Jubilant Radiopharma Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications

Table 143. Jubilant Radiopharma Recent Developments

Table 144. Lantheus Company Information

Table 145. Lantheus Description and Major Businesses

Table 146. Lantheus Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 147. Lantheus Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications

Table 148. Lantheus Recent Developments

Table 149. Aurobindo Pharma Company Information

Table 150. Aurobindo Pharma Description and Major Businesses

Table 151. Aurobindo Pharma Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 152. Aurobindo Pharma Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications

Table 153. Aurobindo Pharma Recent Developments

Table 154. International Isotopes Company Information

Table 155. International Isotopes Description and Major Businesses

Table 156. International Isotopes Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 157. International Isotopes Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications

Table 158. International Isotopes Recent Developments

Table 159. Mundipharma Company Information

Table 160. Mundipharma Description and Major Businesses

Table 161. Mundipharma Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 162. Mundipharma Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications

Table 163. Mundipharma Recent Developments

Table 164. Key Raw Materials Lists

Table 165. Raw Materials Key Suppliers Lists

Table 166. Therapeutic Radioisotopes Distributors List

Table 167. Therapeutic Radioisotopes Customers List

Table 168. Therapeutic Radioisotopes Market Trends

Table 169. Therapeutic Radioisotopes Market Drivers

Table 170. Therapeutic Radioisotopes Market Challenges

Table 171. Therapeutic Radioisotopes Market Restraints

Table 172. Research Programs/Design for This Report

Table 173. Key Data Information from Secondary Sources

Table 174. Key Data Information from Primary Sources

List of Figures

Figure 1. Therapeutic Radioisotopes Product Picture

Figure 2. Global Therapeutic Radioisotopes Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Therapeutic Radioisotopes Market Share by Type in 2023 & 2030

Figure 4. Radium-223 Product Picture

Figure 5. Lutetium-177 Product Picture

Figure 6. Iodine-131 Product Picture

Figure 7. Other Product Picture

Figure 8. Global Therapeutic Radioisotopes Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Therapeutic Radioisotopes Market Share by Application in 2023 & 2030

Figure 10. Thyroid

Figure 11. Bone Metastasis

Figure 12. Lymphoma

Figure 13. Other

Figure 14. Therapeutic Radioisotopes Report Years Considered

Figure 15. Global Therapeutic Radioisotopes Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Therapeutic Radioisotopes Revenue 2019-2030 (US$ Million)

Figure 17. Global Therapeutic Radioisotopes Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 18. Global Therapeutic Radioisotopes Revenue Market Share by Region (2019-2030)

Figure 19. Global Therapeutic Radioisotopes Sales 2019-2030 ((K Units)

Figure 20. Global Therapeutic Radioisotopes Sales Market Share by Region (2019-2030)

Figure 21. US & Canada Therapeutic Radioisotopes Sales YoY (2019-2030) & (K Units)

Figure 22. US & Canada Therapeutic Radioisotopes Revenue YoY (2019-2030) & (US$ Million)

Figure 23. Europe Therapeutic Radioisotopes Sales YoY (2019-2030) & (K Units)

Figure 24. Europe Therapeutic Radioisotopes Revenue YoY (2019-2030) & (US$ Million)

Figure 25. China Therapeutic Radioisotopes Sales YoY (2019-2030) & (K Units)

Figure 26. China Therapeutic Radioisotopes Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Asia (excluding China) Therapeutic Radioisotopes Sales YoY (2019-2030) & (K Units)

Figure 28. Asia (excluding China) Therapeutic Radioisotopes Revenue YoY (2019-2030) & (US$ Million)

Figure 29. Middle East, Africa and Latin America Therapeutic Radioisotopes Sales YoY (2019-2030) & (K Units)

Figure 30. Middle East, Africa and Latin America Therapeutic Radioisotopes Revenue YoY (2019-2030) & (US$ Million)

Figure 31. The Therapeutic Radioisotopes Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 32. The Top 5 and 10 Largest Manufacturers of Therapeutic Radioisotopes in the World: Market Share by Therapeutic Radioisotopes Revenue in 2023

Figure 33. Global Therapeutic Radioisotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 34. Global Therapeutic Radioisotopes Sales Market Share by Type (2019-2030)

Figure 35. Global Therapeutic Radioisotopes Revenue Market Share by Type (2019-2030)

Figure 36. Global Therapeutic Radioisotopes Sales Market Share by Application (2019-2030)

Figure 37. Global Therapeutic Radioisotopes Revenue Market Share by Application (2019-2030)

Figure 38. US & Canada Therapeutic Radioisotopes Sales Market Share by Type (2019-2030)

Figure 39. US & Canada Therapeutic Radioisotopes Revenue Market Share by Type (2019-2030)

Figure 40. US & Canada Therapeutic Radioisotopes Sales Market Share by Application (2019-2030)

Figure 41. US & Canada Therapeutic Radioisotopes Revenue Market Share by Application (2019-2030)

Figure 42. US & Canada Therapeutic Radioisotopes Revenue Share by Country (2019-2030)

Figure 43. US & Canada Therapeutic Radioisotopes Sales Share by Country (2019-2030)

Figure 44. U.S. Therapeutic Radioisotopes Revenue (2019-2030) & (US$ Million)

Figure 45. Canada Therapeutic Radioisotopes Revenue (2019-2030) & (US$ Million)

Figure 46. Europe Therapeutic Radioisotopes Sales Market Share by Type (2019-2030)

Figure 47. Europe Therapeutic Radioisotopes Revenue Market Share by Type (2019-2030)

Figure 48. Europe Therapeutic Radioisotopes Sales Market Share by Application (2019-2030)

Figure 49. Europe Therapeutic Radioisotopes Revenue Market Share by Application (2019-2030)

Figure 50. Europe Therapeutic Radioisotopes Revenue Share by Country (2019-2030)

Figure 51. Europe Therapeutic Radioisotopes Sales Share by Country (2019-2030)

Figure 52. Germany Therapeutic Radioisotopes Revenue (2019-2030) & (US$ Million)

Figure 53. France Therapeutic Radioisotopes Revenue (2019-2030) & (US$ Million)

Figure 54. U.K. Therapeutic Radioisotopes Revenue (2019-2030) & (US$ Million)

Figure 55. Italy Therapeutic Radioisotopes Revenue (2019-2030) & (US$ Million)

Figure 56. Russia Therapeutic Radioisotopes Revenue (2019-2030) & (US$ Million)

Figure 57. China Therapeutic Radioisotopes Sales Market Share by Type (2019-2030)

Figure 58. China Therapeutic Radioisotopes Revenue Market Share by Type (2019-2030)

Figure 59. China Therapeutic Radioisotopes Sales Market Share by Application (2019-2030)

Figure 60. China Therapeutic Radioisotopes Revenue Market Share by Application (2019-2030)

Figure 61. Asia Therapeutic Radioisotopes Sales Market Share by Type (2019-2030)

Figure 62. Asia Therapeutic Radioisotopes Revenue Market Share by Type (2019-2030)

Figure 63. Asia Therapeutic Radioisotopes Sales Market Share by Application (2019-2030)

Figure 64. Asia Therapeutic Radioisotopes Revenue Market Share by Application (2019-2030)

Figure 65. Asia Therapeutic Radioisotopes Revenue Share by Region (2019-2030)

Figure 66. Asia Therapeutic Radioisotopes Sales Share by Region (2019-2030)

Figure 67. Japan Therapeutic Radioisotopes Revenue (2019-2030) & (US$ Million)

Figure 68. South Korea Therapeutic Radioisotopes Revenue (2019-2030) & (US$ Million)

Figure 69. China Taiwan Therapeutic Radioisotopes Revenue (2019-2030) & (US$ Million)

Figure 70. Southeast Asia Therapeutic Radioisotopes Revenue (2019-2030) & (US$ Million)

Figure 71. India Therapeutic Radioisotopes Revenue (2019-2030) & (US$ Million)

Figure 72. Middle East, Africa and Latin America Therapeutic Radioisotopes Sales Market Share by Type (2019-2030)

Figure 73. Middle East, Africa and Latin America Therapeutic Radioisotopes Revenue Market Share by Type (2019-2030)

Figure 74. Middle East, Africa and Latin America Therapeutic Radioisotopes Sales Market Share by Application (2019-2030)

Figure 75. Middle East, Africa and Latin America Therapeutic Radioisotopes Revenue Market Share by Application (2019-2030)

Figure 76. Middle East, Africa and Latin America Therapeutic Radioisotopes Revenue Share by Country (2019-2030)

Figure 77. Middle East, Africa and Latin America Therapeutic Radioisotopes Sales Share by Country (2019-2030)

Figure 78. Brazil Therapeutic Radioisotopes Revenue (2019-2030) & (US$ Million)

Figure 79. Mexico Therapeutic Radioisotopes Revenue (2019-2030) & (US$ Million)

Figure 80. Turkey Therapeutic Radioisotopes Revenue (2019-2030) & (US$ Million)

Figure 81. Israel Therapeutic Radioisotopes Revenue (2019-2030) & (US$ Million)

Figure 82. GCC Countries Therapeutic Radioisotopes Revenue (2019-2030) & (US$ Million)

Figure 83. Therapeutic Radioisotopes Value Chain

Figure 84. Therapeutic Radioisotopes Production Process

Figure 85. Channels of Distribution

Figure 86. Distributors Profiles

Figure 87. Bottom-up and Top-down Approaches for This Report

Figure 88. Data Triangulation

Figure 89. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-3J10777

Thu Feb 20 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Enteral Medicine Straw Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-31N10509

Thu Feb 20 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Bupropion Hydrochloride Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4W9519

Thu Feb 20 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Calcium Dobesilate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24P10026

Thu Feb 20 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Therapeutic Radioisotopes Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-36G14063

Global Therapeutic Radioisotopes Market Insights, Forecast to 2030

FEATURED COMPANIES

Therapeutic Radioisotopes Market Size

Therapeutic Radioisotopes Market

Scope of Therapeutic Radioisotopes Market Report

Chapter Outline

FAQ for this report

How fast is Therapeutic Radioisotopes Market growing?

What is the Therapeutic Radioisotopes Market size in 2030?

Who are the main players in the Therapeutic Radioisotopes Market report?

What are the Application segmentation covered in the Therapeutic Radioisotopes Market report?

What are the Type segmentation covered in the Therapeutic Radioisotopes Market report?

FEATURED COMPANIES

RELATED REPORTS

$5800

Enterprise User

$5800

Enterprise User

$5800

Enterprise User

$5800

Enterprise User